Millipore Sues W.L. Gore & Associates for Patent Infringement
Millipore Corporation (Billerica, MA) has filed a lawsuit in the US District Court for the District of Massachusetts against W.L. Gore & Associates for infringement of Millipore's patent rights under US Patent No. 7,293,477, "Disposable, Pre-Sterilized Fluid Receptacle Sampling Device."
Millipore Corporation (Billerica, MA) has filed a lawsuit in the US District Court for the District of Massachusetts against W.L. Gore & Associates for infringement of Millipore’s patent rights under US Patent No. 7,293,477, “Disposable, Pre-Sterilized Fluid Receptacle Sampling Device.”
Millipore’s suit claims that W.L. Gore’s STA-PURE sampler products compete with components of Millipore’s NovaSeptumsampling system. The NovaSeptum sampling system is a sterile, disposable, completely enclosed sampling system for aseptic and sterile processes.
W.L. Gore denies any wrongdoing. “Gore believes the complaint to be without merit and has answered the complaint,” said Jacques Rene of W.L. Gore. “Gore contends that the 477 patent is invalid and not infringed by any Gore product.”
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
